The development of transgenic plants constitutes an important step in the discovery of novel agronomic traits. Agrobacterium tumefaciens is a commonly used vehicle in plant genetic engineering, delivering foreign DNA into plant cells through its T-DNA transfer system.
The optimized combination of T-DNA vectors, Agrobacterium strains and phytohormones often helps in establishing high transformation rates in crops. However, the process can result in unintended outcomes, such as the insertion of truncated or multiple copies of T-DNA. These issues can result in altered gene expression, instability in subsequent generations, and undesired phenotypic traits in the plants. Ultimately, these inconsistencies increase the time and cost required to develop stable, market-ready transgenic plants and limit the reliability of the transformation process for commercial applications.
Improving the precision and stability of single T-DNA integrations would enhance the overall success and efficiency of plant transformation procedures.
We are seeking to collaborate with researchers and organizations to develop a protocol that improves the efficiency of Agrobacterium transformations, generating high proportions of transgenic plants with intact, single copy T-DNA insertions through tissue culture regeneration.
As a global chemical company, we operate in diverse markets with varying requirements. To ensure responsible conduct and maintain our license to operate, we are guided by our core values and standards. These values shape our daily actions and foster respectful relationships with colleagues, customers, and partners.
Our teams are committed to putting health and safety first, making sustainability a part of every decision, and meeting strict compliance and environmental standards. We embrace diversity—in people, perspectives, and experiences—and promote open feedback grounded in honesty, respect, and trust. We see setbacks as opportunities to learn and improve.
Learn moreThe Q&A is now closed.